Bladder Cancer
"A Multicenter Trial Evaluation of the Fibrin/Fibrinogen Degradation Products Test for Detection and Monitoring of Bladder Cancer."
Published in Cancer Weekly, October 20th, 1997
According to the authors' abstract of an article published in Journal of Urology, "Purpose: Presently there is a lack of effective, noninvasive tests for the detection and monitoring of bladder cancer. Measurement of fibrin/fibrinogen degradation products in urine has been shown to be a useful indicator of bladder carcinoma. The objective of this study was to evaluate the AuraTek FDP* rapid immunoassay device for the detection of urinary fibrin/ fibrinogen degradation products associated with bladder cancer. Materials and Methods: A prospective multicenter study was conducted to compare AuraTek FDP with urinary cytology and hemoglobin dipstick for the detection of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1997-10-20)
More Articles from Cancer Weekly
- Immunology
TNF(alpha) Facilitates Immune-Mediated Clearance of Adenoviral Vectors - Immunology
New Cell Pathway For Triggering Immune System Response Discovered - Breast Cancer (Education)
DoD Enlists the Network Connection in Battle Against Cancer - Breast Cancer (Phytoestrogens)
Diet Can Reduce Risk of Breast Cancer - Breast Cancer (Therapy)
Femara - Advanced Breast Cancer Drug - Now Available - Breast Cancer (Therapy)
Radiation Cuts Cancer Deaths - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
